Patient safety and POCT

  • Mario Plebani


In laboratory medicine quality assessment demands that every step along the total testing chain is performed correctly and accurately to ensure valuable decision-making along with safe and effective patient care. This applies also to POCT. In practice, however, POCT creates other challenges from a risk management perspective, namely analyses performed by non-laboratory personnel, poor quality control, non-conforming quality assessment workflows and great vulnerability in the pre-analytical phase. Even if most laboratory errors do not impact patient outcomes, the potential to injure patients is inherent and, for that reason, every potential risk of error deserves commensurate investigation, response and prevention in order to optimize patient safety.


  1. 1.
    Boyd JC, Bruns DE (2001) Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 47:209–14Google Scholar
  2. 2.
    Carraro P, Plebani M (2009) Post-analytical errors with portable glucose meters in the hospital setting. Clin Chim Acta 404:65–7CrossRefGoogle Scholar
  3. 3.
    Collinson PO (2006) Cardiac biomarkers. Pathophysiology and disease management. IN: Totowa NJ (ed): Humana Humana Press, pp 559–74Google Scholar
  4. 4.
    Fraser CG (2001) Biological variation: from principles to practice. AACC Press, WashingtonGoogle Scholar
  5. 5.
    Freedman DB (2002) Clinical governance: implications for point-of-care testing. Ann Clin Biochem 39:421–3CrossRefPubMedGoogle Scholar
  6. 6.
    Gray TA, Freedman DB, Burnett D, Szczepura A, Price CP (1996) Evidence based practice: clinicians’ use and attitudes to near patient testing in hospital. J Clin Pathol 49:903–8CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hawkins RC (2006) Correction and reporting of potassium results in haemolysed samples. Ann Clin Biochem 43:88–9CrossRefPubMedGoogle Scholar
  8. 8.
    Hyltoft Petersen P, Brandslund I, Jørgensen L, Stahl M, de Fine Olivarius N, Borch-Johnsen K (2001) Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 61(3):191–204Google Scholar
  9. 9.
    Jani IV, Peter TF (2013) How Point-of-Care testing could drive innovation in global health. N Engl J Med 368: 2319–24CrossRefPubMedGoogle Scholar
  10. 10.
    José RJ, Preller J (2008) Near-patient testing of potassium levels using arterial blood gas analysers: can we trust these results? Emerg Med J 25:510–3CrossRefPubMedGoogle Scholar
  11. 11.
    Kazmierczak S (2008) Improving healthcare through advances in point-of-care technologies. Clin Chem Lab Med 46:1–2CrossRefPubMedGoogle Scholar
  12. 12.
    Kristensen GB, Sandberg S (2010) Self-monitoring of blood glucose with a focus on analytical quality: an overview. Clin Chem Lab Med 48:963–72Google Scholar
  13. 13.
    Kost GJ (1995) Guidelines for point-of-care testing. Improving patient outcomes. Am J Clin Pathol 104:S111–S127Google Scholar
  14. 14.
    Larsson A, Greig-Pylypczuk R, Huisman A (2015) The state of point-of-care testing: a European perspective. Ups J Med Sci 120:1–10CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. (2008) Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 46:764–72Google Scholar
  16. 16.
    Meier FA, Jones BA (2005) Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 129:1262–7Google Scholar
  17. 17.
    Mirzazadeh M, Morovat A, James T, Smith I, Kirby J, Shine B (2016) Point-of-care testing of electrolytes and calcium using blood gas analysers: it is time we trusted the results. Emerg Med J 33:181–6CrossRefPubMedGoogle Scholar
  18. 18.
    O’Kane MJ, McManus P, McGowan N, Lynch PL (2011) Quality error rates in point-of-care testing. Clin Chem 57:1267–71CrossRefPubMedGoogle Scholar
  19. 19.
    Palamalai V, Murakami MM, Apple FS (2013) Diagnostic performance of four point ofcare cardiac troponin I assays to rule in and rule out acute myocardial infarction. Clin Biochem 46:1631–5CrossRefPubMedGoogle Scholar
  20. 20.
    Plebani M (2009) Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta 404:59–64CrossRefGoogle Scholar
  21. 21.
    Plebani M (2012) Quality indicators to detect pre-analytical errors in laboratory test. Clin Biochem Rev 33:85–8Google Scholar
  22. 22.
    Plebani M (2013) Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 51:741–51Google Scholar
  23. 23.
    Plebani M (2016) Harmonization in laboratory medicine: Requests, samples, measurements and reports. Crit Rev Clin Lab Sci 53:184–96CrossRefPubMedGoogle Scholar
  24. 24.
    Rainey PM, Ulibarri M (2014) Point-of-Care Testing. Is faster better? Am J Clin Pathol 142:582–3CrossRefPubMedGoogle Scholar
  25. 25.
    Sharp L, Farrance I, Greaves RF (2016The application of glucose point of care testing in three metropolitan hospitals. Pathology 48:51–9CrossRefPubMedGoogle Scholar
  26. 26.
    St John A, Price CP (2014) Existing and emerging technologies for Point-of-Care Testing. Clin Biochem Rev 35:155–67Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Mario Plebani
    • 1
  1. 1.University Hospital of PadovaDepartment of Laboratory MedicinePadovaItaly

Personalised recommendations